Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 2: tratamiento-Reference-Cited by-同舟云学术

Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 2: tratamiento

Published:2022-11 Issue:9 Volume:18 Page:501-512
ISSN:1699-258X
Container-title:Reumatología Clínica
language:es
Short-container-title:Reumatología Clínica

Author:

Narváez Javier^ORCID,Díaz del Campo Fontecha Petra,Brito García Noé,Bonilla Gema^ORCID,Aburto Myriam^ORCID,Castellví Iván,Cano-Jiménez Esteban,Mena-Vázquez Natalia,Nieto M. Asunción,Ortiz Ana María,Valenzuela Claudia,Abad Hernández Miguel Ángel,Castrejón Isabel^ORCID,Correyero Plaza María,Francisco Hernández Félix Manuel,Hernández Hernández María Vanesa,Rodríquez Portal José Antonio

Publisher

Elsevier BV

Subject

Rheumatology

Reference106 articles.

1. Pulmonary complications of rheumatoid arthritis;Farquhar;Semin Respir Crit Care Med.,2019

2. Lung disease in rheumatoid arthritis;Yunt;Rheum Dis Clin North Am.,2015

3. The lung in rheumatoid arthritis: Focus on interstitial lung disease;Spagnolo;Arthritis Rheumatol.,2018

4. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study;Bongartz;Arthritis Rheum.,2010

5. Predictors of mortality in rheumatoid arthritis-related interstitial lung disease;Assayag;Respirology.,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis;Autoimmunity Reviews;2024-09

2. Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs;Expert Opinion on Investigational Drugs;2024-07-05

3. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

4. Safety of Tocilizumab on Rheumatoid Arthritis in Patients with Interstitial Lung Disease;Open Access Rheumatology: Research and Reviews;2024-06

5. Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register;RMD Open;2024-04